Clinical application of the Panbio™ COVID-19 Ag rapid test device and SSf-COVID19 kit for the detection of SARS-CoV-2 infection.

Sang-Min OhJee-Soo LeeHyeon Jae JoDonghwan KimDohyeon ParkYoung Hoon HwangYunsang ChoiChan Mi LeeSeungjae LeeEuijin ChangEunyoung LeeTaek Soo KimMoon-Woo SeongPyoeng Gyun ChoeNam Joong Kim

Published in: BMC research notes (2022)

In total, 157 patients were investigated; 124 patients who were about to be hospitalized and 33 patients already admitted for COVID-19. The overall sensitivity and specificity of the Panbio™ COVID-19 Ag rapid test device with nasal swabs were 64.7% (95% confidence interval [CI] 47.9-78.5%) and 100.0% (95% CI 97.0-100.0%), respectively. The median time to confirm a positive result was 180 s (interquartile range 60-255 s). The overall sensitivity and specificity of the SSf-COVID19 kit with saliva specimens were 94.1% (95% CI 80.9-98.4%) and 100.0% (95% CI 97.0-100.0%), respectively.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
respiratory syndrome coronavirus
prognostic factors
peritoneal dialysis
loop mediated isothermal amplification
mass spectrometry
highly efficient
sensitive detection